Pharmacological properties of the ubiquitous natural product betulin

European Journal of Pharmaceutical Sciences

Volumn 29, Issue 1, 2006, Pages 1-13

  Alakurtti, Sami ^b   Mäkelä, Taru ^a   Koskimies, Salme ^a   Yli Kauhaluoma, Jari ^b  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Betula sp.; Betulin; Betulin derivatives; Betulinic acid; Birch bark; Medicinal chemistry; Natural products

Indexed keywords

3 O (3,3 DIMETHYLSUCCINYL)BETULIC ACID; 4 (8 BETULINOYLAMINOOCTANOYLAMINO) 3 HYDROXY 6 METHYLHEPTANOIC ACID; ASPARAGINASE; BETULIC ACID; BETULIC ACID DERIVATIVE; BETULIN; CARMUSTINE; CISPLATIN; DACTINOMYCIN; DEXAMETHASONE; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; DSB 30; ETOPOSIDE; INDINAVIR; LH 15; LH55 33; LUPEOL; NATURAL PRODUCT; PACLITAXEL; PHENYLBUTAZONE; PREDNISOLONE; TERPENOID DERIVATIVE; TIOGUANINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE; YK FH312; ZIDOVUDINE;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CYTOTOXICITY; DERIVATIZATION; DRUG MECHANISM; DRUG POTENTIATION; EDEMA; ELECTRON TRANSPORT; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN INFLAMMATION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIMALARIALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; HUMANS; TRITERPENES;

EID: 33747802067     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2006.04.006     Document Type: Review

References (84)

1. Aiken C., and Chen C.H. Betulinic acid derivatives as HIV-1 antivirals. Trends Mol. Med. 11 (2005) 31-36
2. Akihisa T., Takamine Y., Yoshizumi K., Tokuda H., Kimura Y., Ukiya M., Nakahara T., Yokochi T., Ichiishi E., and Nishino H. Microbial transformations of two lupane-type triterpenes and anti-tumor-promoting effects of the transformation products. J. Nat. Prod. 65 (2002) 278-282
3. Baglin I., Mitaine-Offer A.C., Nour M., Tan K., Cave C., and Lacaille-Dubois M.A. A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents. Mini Rev. Med. Chem. 3 (2003) 525-539
4. Baglin I., Poumaroux A., Nour M., Tan K., Mitaine-Offer A.C., Lacaille-Dubois M.A., Chauffert B., and Cave C. New ursolic and betulinic derivatives as potential cytotoxic agents. J. Enzyme Inhib. Med. Chem. 18 (2003) 111-117
5. Baltina L.A., Flekhter O.B., Nigmatullina L.R., Boreko E.I., Pavlova N.I., Nikolaeve S.N., Savinova O.V., and Tolstikov G.A. Lupane triterpenes and derivatives with antiviral activity. Bioorg. Med. Chem. Lett. 13 (2003) 3549-3552
6. Bernard P., Scior T., Didier B., Hibert M., and Berthon J. Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A2 inhibitors. Phytochemistry 58 (2001) 865-874
7. Chatterjee P., Kouzi S.A., Pezzuto J.M., and Hamann M.T. Biotransformation of the antimelanoma agent betulinic acid by Bacillus megaterium ATCC 13368. Appl. Environ. Microbiol. 66 (2000) 3850-3855
8. Chowdhury A.R., Mandal S., Mittra B., Sharma S., Mukhopadhyay S., and Majumder H.K. Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives. Med. Sci. Monit. 8 (2002) br254-br260
9. Cichewicz R.H., and Kouzi S.A. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med. Res. Rev. 24 (2003) 90-114
10. Deng Y., and Snyder J.K. Preparation of a 24-Nor-1,4-dien-3-one triterpene derivative from betulin: a new route to 24-nortriterpene analogues. J. Org. Chem. 67 (2002) 2864-2873
11. Duker-Eshun G., Jaroszewski J.W., Asomaning W.A., Oppong-Boachie F., and Christensen S.B. Antiplasmodial constituents of Cajanus cajan. Phytother. Res. 18 (2004) 128-130
12. Eckerman C., and Ekman R. Comparison of solvents for extraction and crystallization of betulinol from birch bark waste. Paperi ja Puu 67 (1985) 100-106
13. Eder-Czembirek C., Czembirek C., Erovic B.M., Selzer E., Turhani D., Vormittag L., and Thurnher D. Combination of betulinic acid with cisplatin-different cytotoxic effects in two head and neck cancer cell lines. Oncol. Rep. 14 (2005) 667-671
14. Ehrhardt H., Fulda S., Fuhrer M., Debatin K., and Jeremias I. Betulinic acid-induced apoptosis in leukemia cells. Leukemia 18 (2004) 1406-1412
15. Eiznhamer D.A., and Xu Z. Betulinic acid: a promising anticancer candidate. IDrugs: Investig. Drugs J. 7 (2004) 359-373
16. Evers M., Poujade C., Soler F., Ribeill Y., James C., Lelievre Y., Gueguen J.C., Reisdorf D., Morize I., Pauwels R., De Clercq E., Henin Y., Bousseau A., Mayaux J.F., Le Pecq J.B., and Dereu N. Betulinic acid derivatives: a new class of Human Immunodeficiency Virus type 1 specific inhibitors with a new mode of action. J. Med. Chem. 39 (1996) 1056-1068
17. Flekhter O.B., Karachurina L.T., Nigmatullina L.R., Sapozhnikova T.A., Baltina L.A., Zarudii F.S., Galin F.Z., Spirikhin L.V., Tolstikov G.A., Plyasunova O.A., and Pokrovskii A.G. Synthesis and pharmacological activity of betulin dinicotinate. Russ. J. Bioorg. Chem. 28 (2002) 494-500
18. Flekhter O.B., Nigmatullina L.R., Baltina L.A., Karachurina L.T., Galin F.Z., Zarudii F.S., Tolstikov G.A., Boreko E.I., Pavlova N.I., Nikolaeva S.N., and Savinova O.V. Synthesis of betulinic acid from betulin extract and study of the antiviral and antiulcer activity of some related terpenoids. Pharm. Chem. J. 36 (2002) 484-487
19. Flekhter O.B., Ashavina O.Y., Boreko E.I., Karachurina L.T., Pavlova N.I., Kabalnova N.N., Savinova O.V., Galin F.Z., Nikolaeva S.N., Zarudii F.S., Baltina L.A., and Tolstikov G.A. Synthesis of 3-O-acetylbetulinic and betulonic aldehydes according to Svern and the pharmacological activity of related oximes. Pharm. Chem. J. 36 (2002) 303-306
20. Flekhter O.B., Medvedeva N.I., Karachurina L.T., Baltina L.A., Zarudii F.S., Galin F.Z., and Tolstikov G.A. Synthesis and antiinflammatory activity of new acylated betulin derivatives. Pharm. Chem. J. 36 (2002) 488-491
21. Flekhter O.B., Boreko E.I., Nigmatullina L.R., Tret'yakova E.V., Pavlova N.I., Baltina L.A., Nikolaeva S.N., Savinova O.V., Galin F.Z., and Tolstikov G.A. Synthesis and antiviral activity of ureides and carbamates of betulinic acid and its derivatives. Russ. J. Bioorg. Chem. 29 (2003) 594-600
22. Fulda S., and Debatin K. Sensitization for anticancer drug-induced apoptosis by betulinic acid. Neoplasia 7 (2005) 162-170
23. Fulda S., Friesen C., Los M., Scaffidi C., Mier W., Benedict M., Nunez G., Krammer P.H., Peter M.E., and ebatin K. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 57 (1997) 4956-4964
24. Fulda S., Jeremias I., and Debatin K. Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells. Oncogene 23 (2004) 7611-7620
25. Fulda S., Jeremias I., Steiner H.H., Pietsch T., and Debatin K. Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int. J. Cancer 82 (1999) 435-441
26. Fulda S., Susin S.A., Kroemer G., and Debatin K. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res. 58 (1998) 4453-4460
27. Fulda S., Scaffidi C., Susin S.A., Krammer P.H., Kroemer G., Peter M.E., and Debatin K. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem. 273 (1998) 33942-33948
28. Gao H., Wu L., Kuroyanagi M., Harada K., Kawahara N., Nakane T., Umehara K., Hirasawa A., and Nakamura Y. Antitumor-promoting constituents from Chaenomeles sinensis Koehne and their activities in JB6 mouse epidermal cells. Chem. Pharm. Bull. 51 (2003) 1318-1321
29. Hänsel R., Keller K., Rimpler H., and Schneider G. Drogen A-D: Betula (1992), Springer Verlag, Berlin
30. Hashimoto F., Kashiwada Y., Cosentino L.M., Chen C., Garrett P.E., and Lee K. Anti-AIDS agents: XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives. Bioorg. Med. Chem. 5 (1997) 2133-2143
31. Hata K., Hori K., and Takahashi S. Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line. J. Nat. Prod. 65 (2002) 645-648
32. Hata K., Hori K., Ogasawara H., and Takahashi S. Anti-leukemia activities of lup-28-al-20(29)-en-3-one, a lupane triterpene. Toxicol. Lett. 143 (2003) 1-7
33. Hess S.C., Brum R.L., Honda N.K., Cruz A.B., Moretto E., Cruz R.B., Messana I., Ferrari F., Cechinel Filho V., and Yunes R.A. Antibacterial activity and phytochemical analysis of Vochysia divergens (Vochysiaceae). J. Ethnopharmacol. 47 (1995) 97-100
34. Holz-Smith S.L., Sun I., Jin L., Matthews T.J., Lee K., and Chen C.H. Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564. Antimicrob. Agents Chemother. 45 (2001) 60-66
35. Huang L., and Chen C.H. Molecular targets of anti-HIV-1 triterpenes. Curr. Drug Target Infect. Disord. 2 (2002) 33-36
36. Huang L., Yuan X., Aiken C., and Chen C.H. Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action. Antimicrob. Agents Chemother. 48 (2004) 663-665
37. Huguet A.I., del Carmen Recio M., Manez S., Giner R.M., and Rios J.L. Effect of triterpenoids on the inflammation induced by protein kinase C activators, neuronally acting irritants and other agents. Eur. J. Pharmacol. 410 (2000) 69-81
38. Jeong H., Chai H., Park S., and Kim D.S.H.L. Preparation of amino acid conjugates of betulinic acid with activity against human melanoma. Bioorg. Med. Chem. Lett. 9 (1999) 1201-1204
39. Jeremias I., Steiner H.H., Benner A., Debatin K.M., and Herold-Mende C. Cell death induction by betulinic acid, ceramide and TRAIL in primary glioblastoma multiforme cells. Acta Neurochir. 146 (2004) 721-729
40. Kanamoto T., Kashiwada Y., Kanbara K., Gotoh K., Yoshimori M., Goto T., Sano K., and Nakashima H. Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Antimicrob. Agents Chemther. 45 (2001) 1225-1230
41. Karachurina L.T., Sapozhnikova T.A., Zarudii F.S., Flekhter O.B., and Galin F.Z. Antiinflammatory and antiulcer properties of betulin bis-hemiphthalate. Pharm. Chem. J. 36 (2002) 432-433
42. Kashiwada Y., Chiyo J., Ikeshiro Y., Nagao T., Okabe H., Cosentino L.M., Fowke K., and Lee K.H. 3,28-Di-O-(dimethylsuccinyl)-betulin isomers as anti-HIV agents. Bioorg. Med. Chem. Lett. 11 (2001) 183-185
43. Kashiwada Y., Hashimoto F., Cosentino L.M., Chen C., Garrett P.E., and Lee K. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. J. Med. Chem. 39 (1996) 1016-1017
44. Kashiwada Y., Nagao T., Hashimoto A., Ikeshiro Y., Okabe H., Cosentino L.M., and Lee K. Anti-AIDS agents 38. Anti-HIV activity of 3-O-acylursolic acid derivatives. J. Nat. Prod. 63 (2000) 1619-1622
45. Kasperczyk H., La Ferla-Bruehl K., Westhoff M.A., Behrend L., Zwacka R.M., Debatin K., and Fulda S. Betulinic acid as new activator of NF-κB: molecular mechanisms and implications for cancer therapy. Oncogene 24 (2005) 6945-6956
46. Kim D.S.H.L., Chen Z., Van Tuyen N., Pezzuto J.M., Qiu S., and Lu Z. A concise semi-synthetic approach to betulinic acid from betulin. Synth. Commun. 27 (1997) 1607-1612
47. Kim D.S.H.L., Pezzuto J.M., and Pisha E. Synthesis of betulinic acid derivatives with activity against human melanoma. Bioorg. Med. Chem. Lett. 8 (1998) 1707-1712
48. Kim J.Y., Koo H.M., and Kim D.S.H.L. Development of C-20 modified betulinic acid derivatives as antitumor agents. Bioorg. Med. Chem. Lett. 11 (2001) 2405-2408
49. Kouzi S.A., Chatterjee P., Pezzuto J.M., and Hamann M.T. Microbial transformations of the antimelanoma agent betulinic acid. J. Nat. Prod. 63 (2000) 1653-1657
50. Li F., Goila-gaur R., Salzwedel K., Kilgore N.R., Reddick M., Matallana C., Castillo A., Zoumplis D., Martin D.E., Orenstein J.M., Allaway G.P., Freed E.O., and Wild C.T. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13555-13560
51. Liu W., Ho J.C.K., Cheung F.W.K., Liu B.P.L., Ye W., and Che C. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line. Eur. J. Pharmacol. 498 (2004) 71-78
52. Manez S., Recio M.C., Giner R.M., and Rios J.L. Effect of selected triterpenoids on chronic dermal inflammation. Eur. J. Pharmacol. 334 (1997) 103-105
53. Mayaux J.F., Bousseau A., Pauwels R., Huet T., Henin Y., Dereu N., Evers M., Soler F., Poujade C., De Clercq E., and Le Pecq J.B. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Proc. Natl. Acad. Sci. 91 (1994) 3564-3568
54. Meng R.D., and El-Deiry W.S. p53-Independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-g. Exp. Cell Res. 262 (2001) 154-169
55. Mukherjee P.K., Saha K., Das J., Pal M., and Saha B.P. Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta Med. 63 (1997) 367-369
56. Mukherjee R., Jaggi M., Rajendran P., Siddiqui M.J.A., Srivastava S.K., Vardhan A., and Burman A.C. Betulinic acid and its derivatives as anti-angiogenic agents. Bioorg. Med. Chem. Lett. 14 (2004) 2181-2184
57. Mukherjee R., Jaggi M., Rajendran P., Srivastava S.K., Siddiqui Mohammad J.A., Vardhan A., and Burman A.C. Synthesis of 3-O-acyl/3-benzylidene/3-hydrazone/3-hydrazine/17-carboxyacryloyl ester derivatives of betulinic acid as anti-angiogenic agents. Bioorg. Med. Chem. Lett. 14 (2004) 3169-3172
58. Mukherjee R., Jaggi M., Siddiqui M.J.A., Srivastava S.K., Rajendran P., Vardhan A., and Burman A.C. Synthesis and cytotoxic activity of 3-O-acyl/3-hydrazine/2-bromo/20,29-dibromo betulinic acid derivatives. Bioorg. Med. Chem. Lett. 14 (2004) 4087-4091
59. Nick A., Wright A.D., Rali T., and Sticher O. Antibacterial triterpenoids from Dillenia papuana and their structure-activity relationships. Phytochemistry 40 (1995) 1691-1695
60. Noda Y., Kaiya T., Kohda K., and Kawazoe Y. Enhanced cytotoxicity of some triterpenes toward leukemia L1210 cells cultured in low pH media: possibility of a new mode of cell killing. Chem. Pharm. Bull. 45 (1997) 1665-1670
61. Pavlova N.I., Savinova O.V., Nikolaeva S.N., Boreko E.I., and Flekhter O.B. Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped viruses. Fitoterapia 74 (2003) 489-492
62. Pisha E., Chai H., Lee I.S., Chagwedera T.E., Farnsworth N.R., Cordell G.A., Beecher C.W.W., Fong H.H.S., Kinghorn A.D., Brown D.M., Wani M.C., Wall M.E., Hieken T.J., Das Gupta T.K., and Pezzuto J.M. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1 (1995) 1046-1051
63. Qiu L., Wang Q., Jiang Q., Schefeller E., Derby S., Wanebo H., Yan B., and Wan Y. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. Int. J. Oncol. 27 (2005) 823-830
64. Sarek J., Klinot J., Dzubak P., Klinotova E., Noskova V., Krecek V., Korinkova G., Thomson J.O., Janostakova A., Wang S., Parsons S., Fischer P.M., Zhelev N.Z., and Hajduch M. New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships. J. Med. Chem. 46 (2003) 5402-5415
65. Sawada N., Kataoka K., Kondo K., Arimochi H., Fujino H., Takahashi Y., Miyoshi T., Kuwahara T., Monden Y., and Ohnishi Y. Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice. Br. J. Cancer 90 (2004) 1672-1678
66. Schmidt M.L., Kuzmanoff K.L., Ling-Indeck L., and Pezzuto J.M. Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur. J. Cancer 33 (1997) 2007-2010
67. Selzer E., Pimentel E., Wacheck V., Schlegel W., Pehamberger H., Jansen B., and Kodym R. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J. Invest. Dermatol. 114 (2000) 935-940
68. Soler F., Poujade C., Evers M., Carry J.C., Henin Y., Bousseau A., Huet T., Pauwels R., De Clercq E., Mayaux J.F., Le Pecq J.B., and Dereu N. Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. J. Med. Chem. 39 (1996) 1069-1083
69. Steele J.C.P., Warhust D.C., Kirby G.C., and Simmonds M.S.J. In vitro and in vivo evaluation of betulinic acid as an antimalarial. Phytother. Res. 13 (1999) 115-119
70. Sun I., Chen C., Kashiwada Y., Wu J., Wang H., and Lee K. Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid. J. Med. Chem. 45 (2002) 4271-4275
71. Sun I., Shen J., Wang H., Cosentino L.M., and Lee K. Anti-AIDS agents. 32. synthesis and anti-HIV activity of betulin derivatives. Bioorg. Med. Chem. Lett. 8 (1998) 1267-1272
72. Sun I., Wang H., Kashiwada Y., Shen J., Cosentino L.M., Chen C., Yang L., and Lee K. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents. J. Med. Chem. 41 (1998) 4648-4657
73. Symon A.V., Kaplun A.P., Vlasenkova N.K., Gerasomiva G.K., Shon L.B., Litvin E.F., Kozlova L.M., Surkova E.L., and Shvets V.I. Epimerization of hydroxyl group in lupan series triterpenoids. Russ. J. Bioorg. Chem. 29 (2003) 185-189
74. Takada Y., and Aggarwal B.B. Betulinic acid suppresses carcinogen-induced NF-kB activation through inhibition of IkBa kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J. Immunol. 171 (2003) 3278-3286
75. Tan Y., Yu R., and Pezzuto J.M. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Clin. Cancer Res. 9 (2003) 2866-2875
76. Udeani G.O., Zhao G., Shin Y.G., Cooke B.P., Graham J., Beecher C.W.W., Kinghorn A.D., and Pezzuto J.M. Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice. Biopharm. Drug Dispos. 20 (1999) 379-383
77. Urban M., Sarek J., Klinot J., Korinkova G., and Hajduch M. Synthesis of A-seco derivatives of betulinic acid with cytotoxic activity. J. Nat. Prod. 67 (2004) 1100-1105
78. Wick W., Grimmel C., Wagenknecht B., Dichgans J., and Weller M. Betulinic acid-induced apoptosis in glioma cells: a sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. J. Pharmacol. Exp. Ther. 289 (1999) 1306-1312
79. You Y., Kim Y., Nam N., and Ahn B. Synthesis and cytotoxic activity of A-ring modified betulinic acid derivatives. Bioorg. Med. Chem. Lett. 13 (2003) 3137-3140
80. Yuan X., Huang L., Ho P., Labranche C., and Chen C.H. Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564. Virology 324 (2004) 525-530
81. Zanon M., Piris A., Bersani I., Vegetti C., Molla A., Scarito A., and Anichini A. Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents. Cancer Res. 64 (2004) 7386-7394
82. Zhou J., Yuan X., Dismuke D., Forshey B.M., Lundquist C., Lee K., Aiken C., and Chen C.H. Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation. J. Virol. 78 (2004) 922-929
83. Ziegler H.L., Franzyk H., Sairafianpour M., Tabatabai M., Tehrani M.D., Bagherzadeh K., Hägerstrand H., Staaerk D., and Jaroszewski J.W. Erythrocyte membrane modifying agents and the inhibition of Plasmodium falciparum growth: structure-activity relationships for betulinic acid analogues. Bioorg. Med. Chem. 12 (2004) 119-127
84. Zuco V., Supino R., Righetti S.C., Cleris L., Marchesi E., Gambacorti-Passerini C., and Formelli F. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett. 175 (2002) 17-25